Your browser doesn't support javascript.
loading
Physical Activity Together for People With Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention.
Fakolade, Afolasade; Cameron, Julie; McKenna, Odessa; Finlayson, Marcia L; Freedman, Mark S; Latimer-Cheung, Amy E; Pilutti, Lara A.
Afiliación
  • Fakolade A; School of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada.
  • Cameron J; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
  • McKenna O; Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
  • Finlayson ML; School of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada.
  • Freedman MS; The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Latimer-Cheung AE; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Pilutti LA; School of Kinesiology and Health Studies, Queen's University, Kingston, ON, Canada.
JMIR Res Protoc ; 10(6): e18410, 2021 Jun 01.
Article en En | MEDLINE | ID: mdl-34061040
BACKGROUND: Physical activity (PA) is beneficial for all people; however, people affected by multiple sclerosis (MS) find regular PA challenging. These people may include individuals with advanced disabilities and their care partners. OBJECTIVE: The objective of this study is to determine the feasibility of a dyadic PA intervention for people with advanced MS and their care partners. METHODS: This study is a randomized controlled feasibility trial of a 12-week intervention, with 1:1 allocation into an immediate intervention condition or delayed control condition. A target of 20 people with MS-care partner dyads will be included. The outcomes will be indicators of process, resources, management, and scientific feasibility. Participant satisfaction with the intervention components will be evaluated using a satisfaction survey. The subjective experience of participation in the study will be explored using semistructured interviews. RESULTS: The project is funded by the Consortium of Multiple Sclerosis Centers. This protocol was approved by the Ottawa Hospital Research Ethics Board (20190329-01H) and the University of Ottawa Research Ethics Board (H-09-19-4886). The study protocol was registered with ClinicalTrials.gov in February 2020. The findings of this feasibility trial will be disseminated through presentations at community events to engage the MS population in the interpretation of our results and in the next steps. The results will also be published in peer-reviewed journals and presented to the scientific community at national and international MS conferences. CONCLUSIONS: The data collected from this feasibility trial will be used to refine the intervention and materials in preparation for a pilot randomized controlled trial. TRIAL REGISTRATION: ClinicalTrials.gov NCT04267185; https://clinicaltrials.gov/ct2/show/NCT04267185. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/18410.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Aspecto: Ethics Idioma: En Revista: JMIR Res Protoc Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Aspecto: Ethics Idioma: En Revista: JMIR Res Protoc Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Canadá